Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 190 entries
Sorted by: Best Match Show Resources per page
Nasal Polyposis: More than a Chronic Inflammatory Disorder-A Disease of Mechanical Dysfunction-The São Paulo Position.

International archives of otorhinolaryngology

Pezato R, Voegels RL, Pignatari S, Gregório LC, Pinto Bezerra TF, Gregorio L, Balsalobre L, Tepedino MS, Coronel N, Pinna FR, Mendes Neto J, Oliveira P, Macoto E, Stefanini R, Figueiredo C, Haddad F, Pilan R, Bezerra Soter A, Melo NA, Candido DA, Amaral JD, Santos RP, Van Zele T, Fujita R, Dreyfuss JL, Chamon W, Alencar AM, Perez-Novo C, Stamm AC.
PMID: 30956711
Int Arch Otorhinolaryngol. 2019 Apr;23(2):241-249. doi: 10.1055/s-0038-1676659. Epub 2019 Mar 01.

No abstract available.

Cite
Pezato R, Voegels RL, Pignatari S, et al. Nasal Polyposis: More than a Chronic Inflammatory Disorder-A Disease of Mechanical Dysfunction-The São Paulo Position. Int Arch Otorhinolaryngol. 2019;23(2):241-249doi: 10.1055/s-0038-1676659.
Pezato, R., Voegels, R. L., Pignatari, S., Gregório, L. C., Pinto Bezerra, T. F., Gregorio, L., Balsalobre, L., Tepedino, M. S., Coronel, N., Pinna, F. R., Mendes Neto, J., Oliveira, P., Macoto, E., Stefanini, R., Figueiredo, C., Haddad, F., Pilan, R., Bezerra Soter, A., Melo, N. A., Candido, D. A., Amaral, J. D., Santos, R. P., Van Zele, T., Fujita, R., Dreyfuss, J. L., Chamon, W., Alencar, A. M., Perez-Novo, C., & Stamm, A. C. (2019). Nasal Polyposis: More than a Chronic Inflammatory Disorder-A Disease of Mechanical Dysfunction-The São Paulo Position. International archives of otorhinolaryngology, 23(2), 241-249. https://doi.org/10.1055/s-0038-1676659
Pezato, Rogerio, et al. "Nasal Polyposis: More than a Chronic Inflammatory Disorder-A Disease of Mechanical Dysfunction-The São Paulo Position." International archives of otorhinolaryngology vol. 23,2 (2019): 241-249. doi: https://doi.org/10.1055/s-0038-1676659
Pezato R, Voegels RL, Pignatari S, Gregório LC, Pinto Bezerra TF, Gregorio L, Balsalobre L, Tepedino MS, Coronel N, Pinna FR, Mendes Neto J, Oliveira P, Macoto E, Stefanini R, Figueiredo C, Haddad F, Pilan R, Bezerra Soter A, Melo NA, Candido DA, Amaral JD, Santos RP, Van Zele T, Fujita R, Dreyfuss JL, Chamon W, Alencar AM, Perez-Novo C, Stamm AC. Nasal Polyposis: More than a Chronic Inflammatory Disorder-A Disease of Mechanical Dysfunction-The São Paulo Position. Int Arch Otorhinolaryngol. 2019 Apr;23(2):241-249. doi: 10.1055/s-0038-1676659. Epub 2019 Mar 01. PMID: 30956711; PMCID: PMC6449132.
Copy Download .nbib Format: NLM
The Amplitude-Normalized Area of a Bipolar Electrogram as a Measure of Local Conduction Delay in the Heart.

Frontiers in physiology

Mendonca Costa C, Anderson GC, Meijborg VMF, O'Shea C, Shattock MJ, Kirchhof P, Coronel R, Niederer S, Pavlovic D, Dhanjal T, Winter J.
PMID: 32508676
Front Physiol. 2020 May 19;11:465. doi: 10.3389/fphys.2020.00465. eCollection 2020.

BACKGROUND: Re-entrant ventricular tachycardia may be non-inducible or haemodynamically compromising, requiring assessment of the electrophysiological properties of the myocardium during sinus rhythm (i.e., substrate mapping). Areas of heart tissue with slow conduction can act as a critical isthmus for...

Cite
Mendonca Costa C, Anderson GC, Meijborg VMF, et al. The Amplitude-Normalized Area of a Bipolar Electrogram as a Measure of Local Conduction Delay in the Heart. Front Physiol. 2020;11:465doi: 10.3389/fphys.2020.00465.
Mendonca Costa, C., Anderson, G. C., Meijborg, V. M. F., O'Shea, C., Shattock, M. J., Kirchhof, P., Coronel, R., Niederer, S., Pavlovic, D., Dhanjal, T., & Winter, J. (2020). The Amplitude-Normalized Area of a Bipolar Electrogram as a Measure of Local Conduction Delay in the Heart. Frontiers in physiology, 11465. https://doi.org/10.3389/fphys.2020.00465
Mendonca Costa, Caroline, et al. "The Amplitude-Normalized Area of a Bipolar Electrogram as a Measure of Local Conduction Delay in the Heart." Frontiers in physiology vol. 11 (2020): 465. doi: https://doi.org/10.3389/fphys.2020.00465
Mendonca Costa C, Anderson GC, Meijborg VMF, O'Shea C, Shattock MJ, Kirchhof P, Coronel R, Niederer S, Pavlovic D, Dhanjal T, Winter J. The Amplitude-Normalized Area of a Bipolar Electrogram as a Measure of Local Conduction Delay in the Heart. Front Physiol. 2020 May 19;11:465. doi: 10.3389/fphys.2020.00465. eCollection 2020. PMID: 32508676; PMCID: PMC7248250.
Copy Download .nbib Format: NLM
Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na+/H+ exchanger 1: persistent inhibition under various experimental conditions.

Cardiovascular research

Zuurbier CJ, Baartscheer A, Schumacher CA, Fiolet JWT, Coronel R.
PMID: 33792689
Cardiovasc Res. 2021 Dec 17;117(14):2699-2701. doi: 10.1093/cvr/cvab129.

No abstract available.

Cite
Zuurbier CJ, Baartscheer A, Schumacher CA, et al. Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na+/H+ exchanger 1: persistent inhibition under various experimental conditions. Cardiovasc Res. 2021;117(14):2699-2701doi: 10.1093/cvr/cvab129.
Zuurbier, C. J., Baartscheer, A., Schumacher, C. A., Fiolet, J. W. T., & Coronel, R. (2021). Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na+/H+ exchanger 1: persistent inhibition under various experimental conditions. Cardiovascular research, 117(14), 2699-2701. https://doi.org/10.1093/cvr/cvab129
Zuurbier, Coert J, et al. "Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na+/H+ exchanger 1: persistent inhibition under various experimental conditions." Cardiovascular research vol. 117,14 (2021): 2699-2701. doi: https://doi.org/10.1093/cvr/cvab129
Zuurbier CJ, Baartscheer A, Schumacher CA, Fiolet JWT, Coronel R. Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na+/H+ exchanger 1: persistent inhibition under various experimental conditions. Cardiovasc Res. 2021 Dec 17;117(14):2699-2701. doi: 10.1093/cvr/cvab129. PMID: 33792689.
Copy Download .nbib Format: NLM
Ionic Fluorogels for Remediation of Per- and Polyfluorinated Alkyl Substances from Water.

ACS central science

Kumarasamy E, Manning IM, Collins LB, Coronell O, Leibfarth FA.
PMID: 32341998
ACS Cent Sci. 2020 Apr 22;6(4):487-492. doi: 10.1021/acscentsci.9b01224. Epub 2020 Feb 27.

Per- and polyfluorinated alkyl substances (PFASs) contaminate groundwater, surface water, and finished drinking water internationally. Their ecological persistence and adverse human health effects demand effective remediation approaches. Motivated by the limitations in selectivity and performance of current PFAS removal...

Cite
Kumarasamy E, Manning IM, Collins LB, et al. Ionic Fluorogels for Remediation of Per- and Polyfluorinated Alkyl Substances from Water. ACS Cent Sci. 2020;6(4):487-492doi: 10.1021/acscentsci.9b01224.
Kumarasamy, E., Manning, I. M., Collins, L. B., Coronell, O., & Leibfarth, F. A. (2020). Ionic Fluorogels for Remediation of Per- and Polyfluorinated Alkyl Substances from Water. ACS central science, 6(4), 487-492. https://doi.org/10.1021/acscentsci.9b01224
Kumarasamy, Elango, et al. "Ionic Fluorogels for Remediation of Per- and Polyfluorinated Alkyl Substances from Water." ACS central science vol. 6,4 (2020): 487-492. doi: https://doi.org/10.1021/acscentsci.9b01224
Kumarasamy E, Manning IM, Collins LB, Coronell O, Leibfarth FA. Ionic Fluorogels for Remediation of Per- and Polyfluorinated Alkyl Substances from Water. ACS Cent Sci. 2020 Apr 22;6(4):487-492. doi: 10.1021/acscentsci.9b01224. Epub 2020 Feb 27. PMID: 32341998; PMCID: PMC7181326.
Copy Download .nbib Format: NLM
CD103 Deficiency Promotes Autism (ASD) and Attention-Deficit Hyperactivity Disorder (ADHD) Behavioral Spectra and Reduces Age-Related Cognitive Decline.

Frontiers in neurology

Jhun M, Panwar A, Cordner R, Irvin DK, Veiga L, Yeager N, Pechnick RN, Schubloom H, Black KL, Wheeler CJ.
PMID: 33424735
Front Neurol. 2020 Dec 23;11:557269. doi: 10.3389/fneur.2020.557269. eCollection 2020.

The incidence of autism spectrum disorders (ASD) and attention deficit hyperactivity disorder (ADHD), which frequently co-occur, are both rising. The causes of ASD and ADHD remain elusive, even as both appear to involve perturbation of the gut-brain-immune axis. CD103...

Cite
Jhun M, Panwar A, Cordner R, et al. CD103 Deficiency Promotes Autism (ASD) and Attention-Deficit Hyperactivity Disorder (ADHD) Behavioral Spectra and Reduces Age-Related Cognitive Decline. Front Neurol. 2020;11:557269doi: 10.3389/fneur.2020.557269.
Jhun, M., Panwar, A., Cordner, R., Irvin, D. K., Veiga, L., Yeager, N., Pechnick, R. N., Schubloom, H., Black, K. L., & Wheeler, C. J. (2020). CD103 Deficiency Promotes Autism (ASD) and Attention-Deficit Hyperactivity Disorder (ADHD) Behavioral Spectra and Reduces Age-Related Cognitive Decline. Frontiers in neurology, 11557269. https://doi.org/10.3389/fneur.2020.557269
Jhun, Michelle, et al. "CD103 Deficiency Promotes Autism (ASD) and Attention-Deficit Hyperactivity Disorder (ADHD) Behavioral Spectra and Reduces Age-Related Cognitive Decline." Frontiers in neurology vol. 11 (2020): 557269. doi: https://doi.org/10.3389/fneur.2020.557269
Jhun M, Panwar A, Cordner R, Irvin DK, Veiga L, Yeager N, Pechnick RN, Schubloom H, Black KL, Wheeler CJ. CD103 Deficiency Promotes Autism (ASD) and Attention-Deficit Hyperactivity Disorder (ADHD) Behavioral Spectra and Reduces Age-Related Cognitive Decline. Front Neurol. 2020 Dec 23;11:557269. doi: 10.3389/fneur.2020.557269. eCollection 2020. PMID: 33424735; PMCID: PMC7786306.
Copy Download .nbib Format: NLM
Nutritional and Bioactive Characterization of .

Biology

Caballero S, Mereles L, Burgos-Edwards A, Alvarenga N, Coronel E, Villalba R, Heinichen O.
PMID: 34943266
Biology (Basel). 2021 Dec 19;10(12). doi: 10.3390/biology10121351.

The "Kurugua" (

Cite
Caballero S, Mereles L, Burgos-Edwards A, et al. Nutritional and Bioactive Characterization of . Biology (Basel). 2021;10(12)doi: 10.3390/biology10121351.
Caballero, S., Mereles, L., Burgos-Edwards, A., Alvarenga, N., Coronel, E., Villalba, R., & Heinichen, O. (2021). Nutritional and Bioactive Characterization of . Biology, 10(12), . https://doi.org/10.3390/biology10121351
Caballero, Silvia, et al. "Nutritional and Bioactive Characterization of ." Biology vol. 10,12 (2021). doi: https://doi.org/10.3390/biology10121351
Caballero S, Mereles L, Burgos-Edwards A, Alvarenga N, Coronel E, Villalba R, Heinichen O. Nutritional and Bioactive Characterization of . Biology (Basel). 2021 Dec 19;10(12). doi: 10.3390/biology10121351. PMID: 34943266; PMCID: PMC8698658.
Copy Download .nbib Format: NLM
Empagliflozin reduces oxidative stress through inhibition of the novel inflammation/NHE/[Na.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Uthman L, Li X, Baartscheer A, Schumacher CA, Baumgart P, Hermanides J, Preckel B, Hollmann MW, Coronel R, Zuurbier CJ, Weber NC.
PMID: 34896968
Biomed Pharmacother. 2021 Dec 09;146:112515. doi: 10.1016/j.biopha.2021.112515. Epub 2021 Dec 09.

Inflammation causing oxidative stress in endothelial cells contributes to heart failure development. Sodium/glucose cotransporter 2 inhibitors (SGLT2i's) were shown to reduce heart failure hospitalization and oxidative stress. However, how inflammation causes oxidative stress in endothelial cells, and how SGLT2i's...

Cite
Uthman L, Li X, Baartscheer A, et al. Empagliflozin reduces oxidative stress through inhibition of the novel inflammation/NHE/[Na. Biomed Pharmacother. 2021;146:112515doi: 10.1016/j.biopha.2021.112515.
Uthman, L., Li, X., Baartscheer, A., Schumacher, C. A., Baumgart, P., Hermanides, J., Preckel, B., Hollmann, M. W., Coronel, R., Zuurbier, C. J., & Weber, N. C. (2021). Empagliflozin reduces oxidative stress through inhibition of the novel inflammation/NHE/[Na. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 146112515. https://doi.org/10.1016/j.biopha.2021.112515
Uthman, Laween, et al. "Empagliflozin reduces oxidative stress through inhibition of the novel inflammation/NHE/[Na." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 146 (2021): 112515. doi: https://doi.org/10.1016/j.biopha.2021.112515
Uthman L, Li X, Baartscheer A, Schumacher CA, Baumgart P, Hermanides J, Preckel B, Hollmann MW, Coronel R, Zuurbier CJ, Weber NC. Empagliflozin reduces oxidative stress through inhibition of the novel inflammation/NHE/[Na. Biomed Pharmacother. 2021 Dec 09;146:112515. doi: 10.1016/j.biopha.2021.112515. Epub 2021 Dec 09. PMID: 34896968.
Copy Download .nbib Format: NLM
One-Year, Efficacy and Safety Open Label Study, with a Single Injection of a New Hyaluronan for Knee OA: The SOYA Trial.

Journal of pain research

Gavín C, J Blanco F, L Pablos J, Caracuel MA, Rosas J, Gómez-Barrena E, Navarro F, Coronel MP, Gimeno M.
PMID: 34321921
J Pain Res. 2021 Jul 21;14:2229-2237. doi: 10.2147/JPR.S321841. eCollection 2021.

PURPOSE: To assess the efficacy and safety of a single injection of a new formulation of hyaluronic acid (MPS-HA2%) in patients with symptomatic knee osteoarthritis after 12 months' follow-up.PATIENTS AND METHODS: Prospective, single-arm, multicentre, open-label, 12-month follow-up study. Patients...

Cite
Gavín C, J Blanco F, L Pablos J, et al. One-Year, Efficacy and Safety Open Label Study, with a Single Injection of a New Hyaluronan for Knee OA: The SOYA Trial. J Pain Res. 2021;14:2229-2237doi: 10.2147/JPR.S321841.
Gavín, C., J Blanco, F., L Pablos, J., Caracuel, M. A., Rosas, J., Gómez-Barrena, E., Navarro, F., Coronel, M. P., & Gimeno, M. (2021). One-Year, Efficacy and Safety Open Label Study, with a Single Injection of a New Hyaluronan for Knee OA: The SOYA Trial. Journal of pain research, 142229-2237. https://doi.org/10.2147/JPR.S321841
Gavín, Carlos, et al. "One-Year, Efficacy and Safety Open Label Study, with a Single Injection of a New Hyaluronan for Knee OA: The SOYA Trial." Journal of pain research vol. 14 (2021): 2229-2237. doi: https://doi.org/10.2147/JPR.S321841
Gavín C, J Blanco F, L Pablos J, Caracuel MA, Rosas J, Gómez-Barrena E, Navarro F, Coronel MP, Gimeno M. One-Year, Efficacy and Safety Open Label Study, with a Single Injection of a New Hyaluronan for Knee OA: The SOYA Trial. J Pain Res. 2021 Jul 21;14:2229-2237. doi: 10.2147/JPR.S321841. eCollection 2021. PMID: 34321921; PMCID: PMC8312328.
Copy Download .nbib Format: NLM
Low-cost 3D-printed inverted microscope to detect Mycobacterium tuberculosis in a MODS culture.

Tuberculosis (Edinburgh, Scotland)

Salguedo M, Zarate G, Coronel J, Comina G, Gilman RH, Sheen P, Oberhelman R, Zimic M.
PMID: 34864388
Tuberculosis (Edinb). 2021 Nov 30;132:102158. doi: 10.1016/j.tube.2021.102158. Epub 2021 Nov 30.

MODS, an assay for diagnosis of tuberculosis and drug-susceptibility, is based in the microscopic observation of the characteristic cords of Mycobacterium tuberculosis colonies grown in liquid media. An inverted optical microscope (100× magnification) is required to observe and interpret...

Cite
Salguedo M, Zarate G, Coronel J, et al. Low-cost 3D-printed inverted microscope to detect Mycobacterium tuberculosis in a MODS culture. Tuberculosis (Edinb). 2021;132:102158doi: 10.1016/j.tube.2021.102158.
Salguedo, M., Zarate, G., Coronel, J., Comina, G., Gilman, R. H., Sheen, P., Oberhelman, R., & Zimic, M. (2021). Low-cost 3D-printed inverted microscope to detect Mycobacterium tuberculosis in a MODS culture. Tuberculosis (Edinburgh, Scotland), 132102158. https://doi.org/10.1016/j.tube.2021.102158
Salguedo, Mario, et al. "Low-cost 3D-printed inverted microscope to detect Mycobacterium tuberculosis in a MODS culture." Tuberculosis (Edinburgh, Scotland) vol. 132 (2021): 102158. doi: https://doi.org/10.1016/j.tube.2021.102158
Salguedo M, Zarate G, Coronel J, Comina G, Gilman RH, Sheen P, Oberhelman R, Zimic M. Low-cost 3D-printed inverted microscope to detect Mycobacterium tuberculosis in a MODS culture. Tuberculosis (Edinb). 2021 Nov 30;132:102158. doi: 10.1016/j.tube.2021.102158. Epub 2021 Nov 30. PMID: 34864388.
Copy Download .nbib Format: NLM
Reduced Sodium Current in the Lateral Ventricular Wall Induces Inferolateral J-Waves.

Frontiers in physiology

Meijborg VM, Potse M, Conrath CE, Belterman CN, De Bakker JM, Coronel R.
PMID: 27616994
Front Physiol. 2016 Aug 26;7:365. doi: 10.3389/fphys.2016.00365. eCollection 2016.

BACKGROUND: J-waves in inferolateral leads are associated with a higher risk for idiopathic ventricular fibrillation. We aimed to test potential mechanisms (depolarization or repolarization dependent) responsible for inferolateral J-waves. We hypothesized that inferolateral J-waves can be caused by regional...

Cite
Meijborg VM, Potse M, Conrath CE, et al. Reduced Sodium Current in the Lateral Ventricular Wall Induces Inferolateral J-Waves. Front Physiol. 2016;7:365doi: 10.3389/fphys.2016.00365.
Meijborg, V. M., Potse, M., Conrath, C. E., Belterman, C. N., De Bakker, J. M., & Coronel, R. (2016). Reduced Sodium Current in the Lateral Ventricular Wall Induces Inferolateral J-Waves. Frontiers in physiology, 7365. https://doi.org/10.3389/fphys.2016.00365
Meijborg, Veronique M F, et al. "Reduced Sodium Current in the Lateral Ventricular Wall Induces Inferolateral J-Waves." Frontiers in physiology vol. 7 (2016): 365. doi: https://doi.org/10.3389/fphys.2016.00365
Meijborg VM, Potse M, Conrath CE, Belterman CN, De Bakker JM, Coronel R. Reduced Sodium Current in the Lateral Ventricular Wall Induces Inferolateral J-Waves. Front Physiol. 2016 Aug 26;7:365. doi: 10.3389/fphys.2016.00365. eCollection 2016. PMID: 27616994; PMCID: PMC5000556.
Copy Download .nbib Format: NLM
The impact factor of leading cardiovascular journals: where is your paper best cited?.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

OptHof T, Coronel R.
PMID: 25696090
Neth Heart J. 2002 Apr;10(4):198-202.

No abstract available.

Cite
OptHof T, Coronel R. The impact factor of leading cardiovascular journals: where is your paper best cited?. Neth Heart J. 2002;10(4):198-202
OptHof, T., & Coronel, R. (2002). The impact factor of leading cardiovascular journals: where is your paper best cited?. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 10(4), 198-202.
OptHof, T, and Coronel, R. "The impact factor of leading cardiovascular journals: where is your paper best cited?." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 10,4 (2002): 198-202.
OptHof T, Coronel R. The impact factor of leading cardiovascular journals: where is your paper best cited?. Neth Heart J. 2002 Apr;10(4):198-202. PMID: 25696090; PMCID: PMC2499747.
Copy Download .nbib Format: NLM
Monophasic action potentials and Ca.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Dekker LR, van Bavel E, Opthof T, Coronel R, Janse MJ.
PMID: 25696182
Neth Heart J. 2003 Feb;11(2):62-69.

BACKGROUND: ATP-sensitive KMETHODS: Monophasic action potential duration (MAPD), tissue resistance, intracellular CaRESULTS: In the PC group an increase in the diastolic CaCONCLUSIONS: Prolongation of the Ca

Cite
Dekker LR, van Bavel E, Opthof T, et al. Monophasic action potentials and Ca. Neth Heart J. 2003;11(2):62-69
Dekker, L. R., van Bavel, E., Opthof, T., Coronel, R., & Janse, M. J. (2003). Monophasic action potentials and Ca. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 11(2), 62-69.
Dekker, L R C, et al. "Monophasic action potentials and Ca." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 11,2 (2003): 62-69.
Dekker LR, van Bavel E, Opthof T, Coronel R, Janse MJ. Monophasic action potentials and Ca. Neth Heart J. 2003 Feb;11(2):62-69. PMID: 25696182; PMCID: PMC2499875.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 190 entries